The results of a few studies suggested that the EGFR oncogenic pathway has a synergistic effect on cancer cell proliferation and survival, whereas simultaneous overexpression of GLI1 and MEK1 induces tumour development in studies with BCC [106]. Here, EGFR is linked to skin basal cell carcinoma.